Newsroom Search

featured news

March 5, 2013 General

Par Pharmaceuticals Pleads Guilty to Civil & Criminal Allegations of Off-Label Marketing

Par Pharmaceuticals recently pled guilty in federal court to charges of off-label marketing and will be forced to pay $45 million in order to resolve the company’s criminal and civil liability. Par allegedly promoted its prescription drug, Megace ES, for off-label uses that were not approved as safe or effective […]
$2.4B+
in 2025 post-trial judgments
$50B+
in Settlements & Verdicts
55+
Years of Experience With High-Profile Cases
100+
Attorneys Protecting Your Rights
20+
Years Ranked as Top Law Firm by Chambers USA
50
States in Which The Firm Has Successfully Litigated

On the Cutting Edge of the Profession

Legal Intelligencer